Evidence map›Paper›PMID 25815117›Full record

ReviewWorld journal of stem cells2015

Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.

Dharmendra Kumar, Thirumala R Talluri, Taruna Anand, Wilfried A Kues

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of stem cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Perspectives of pluripotent stem cells in livestock.World journal of stem cells · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Engineering Large Animal Species to Model Human Diseases.Current protocols in human genetics · 2016
    Article
  16. Review
  17. Methylation profile of bovineJournal of integrative agriculture : JIA · 2016
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Dharmendra KumarDharmendra Kumar, Thirumala R Talluri, Taruna Anand, Wilfried A Kues, Institute of Farm Animal Genetics, Friedrich-Loeffler-Institute, 31535 Mariensee, Germany.
Thirumala R TalluriDharmendra Kumar, Thirumala R Talluri, Taruna Anand, Wilfried A Kues, Institute of Farm Animal Genetics, Friedrich-Loeffler-Institute, 31535 Mariensee, Germany.
Taruna AnandDharmendra Kumar, Thirumala R Talluri, Taruna Anand, Wilfried A Kues, Institute of Farm Animal Genetics, Friedrich-Loeffler-Institute, 31535 Mariensee, Germany.
Wilfried A KuesDharmendra Kumar, Thirumala R Talluri, Taruna Anand, Wilfried A Kues, Institute of Farm Animal Genetics, Friedrich-Loeffler-Institute, 31535 Mariensee, Germany.
Friedrich-Loeffler-Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pluripotent stem cells are unspecialized cells with unlimited self-renewal, and they can be triggered to differentiate into desired specialized cell types. These features provide the basis for an unlimited cell source for innovative cell therapies. Pluripotent cells also allow to study developmental pathways, and to employ them or their differentiated cell derivatives in pharmaceutical testing and biotechnological applications. Via blastocyst complementation, pluripotent cells are a favoured tool for the generation of genetically modified mice. The recently established technology to generate an induced pluripotency status by ectopic co-expression of the transcription factors Oct4, Sox2, Klf4 and c-Myc allows to extending these applications to farm animal species, for which the derivation of genuine embryonic stem cells was not successful so far. Most induced pluripotent stem (iPS) cells are generated by retroviral or lentiviral transduction of reprogramming factors. Multiple viral integrations into the genome may cause insertional mutagenesis and may increase the risk of tumour formation. Non-integration methods have been reported to overcome the safety concerns associated with retro and lentiviral-derived iPS cells, such as transient expression of the reprogramming factors using episomal plasmids, and direct delivery of reprogramming mRNAs or proteins. In this review, we focus on the mechanisms of cellular reprogramming and current methods used to induce pluripotency. We also highlight problems associated with the generation of iPS cells. An increased understanding of the fundamental mechanisms underlying pluripotency and refining the methodology of iPS cell generation will have a profound impact on future development and application in regenerative medicine and reproductive biotechnology of farm animals.

Indexed as

ChimeraGene deliveryGermline transmissionInduced pluripotent stem cellsLarge animal modelsReprogrammingStemness

Identifiers

PMID25815117
PMCPMC4369489
OpenAlexW2164013106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.